Case Report of Sotalol Induced IgA Vasculitis

Biniyam   T.   Mohammed; Marwah      Alchalabi; Anna      Laskova; Chenyu      Sun; Owais      Lodhi; Yasmin      Gerais; Ayah Galal      Abdelrahman Alkhidir

Abstract

Background: IgA vasculitis is the most common form of systemic vasculitis in children but can occur in adults. Inciting antigens include infections, drugs, foods, insect bites, and immunizations. Antibiotics and tumor necrosis factor (TNF) alpha inhibitors are the most common class of drugs that cause IgA vasculitis. Although sotalol and rivaroxaban have been documented to cause leukocytoclastic vasculitis, we have never come across any literature attributing IgA vasculitis to either drug. Additionally, Rocky Mountain spotted fever has not been associated with IgA vasculitis despite being described in cutaneous and systemic vasculitis cases. Here, we present a case of IgA vasculitis triggered by sotalol with challenging differentials, including a recent infection with Rocky Mountain spotted fever, malignancy, and rivaroxaban as possible triggers.

Case Presentation: 68 yr old male with a history of lung cancer treated with resection and chemotherapy 5 years ago is currently in remission, and recently was started on sotalol and rivaroxaban for new-onset paroxysmal atrial fibrillation. He presented with diffuse petechial/purpural rash on the lower limbs, multiple joint pain, severe abdominal pain and rectal bleeds, hemoptysis, and renal dysfunction. IgG titers for RMSF were high. Punch biopsy of skin and renal biopsy were consistent with IgA vasculitis. Sotalol and rivaroxaban were stopped. The patient was treated with oral prednisone, and his condition relatively improved.

Conclusion: Ig A vasculitis is mostly a self-limiting disease, but adults tend to have a severe course. It is important to diagnose early and identify a trigger. Removing the offending agent or treating the underlying infection is an important aspect of management.

Keywords: Vasculitis, IgA, sotalol, RMSF, drug-induced, arthralgias.

« Previous Next »

Graphical Abstract

[1]
Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum  2013; 65(1): 1-11.
 [http://dx.doi.org/10.1002/art.37715] [PMID: 23045170]

[2]
Langford CA, Fauci AS. Harrison’s Principles of Internal Medicine. McGraw 2018.

[3]
Piram M, Mahr A. Epidemiology of immunoglobulin A vasculitis (Henoch–Schönlein). Curr Opin Rheumatol  2013; 25(2): 171-8.
 [http://dx.doi.org/10.1097/BOR.0b013e32835d8e2a] [PMID: 23318735]

[4]
Piram M, Maldini C, Biscardi S, et al. Incidence of IgA vasculitis in children estimated by four-source capture-recapture analysis: A population-based study. Rheumatology (Oxford)  2017; 56(8): 1358-66.
 [http://dx.doi.org/10.1093/rheumatology/kex158] [PMID: 28444335]

[5]
Yagnik P, Jain A, Amponsah JK, et al. National trends in the epidemiology and resource use for Henoch-Schönlein Purpura (IgA vasculitis) hospitalizations in the United States from 2006 to 2014. Hosp Pediatr  2019; 9(11): 888-96.
 [http://dx.doi.org/10.1542/hpeds.2019-0131] [PMID: 31575605]

[6]
Blanco R, Martínez-Taboada VM, Rodríguez-Valverde V, García-Fuentes M, González-Gay MA. Henoch-Schönlein purpura in adulthood and childhood. Two different expressions of the same syndrome. Arthritis Rheum  1997; 40(5): 859-64.
 [http://dx.doi.org/10.1002/art.1780400513] [PMID: 9153547]

[7]
Hočevar A, Rotar Z, Ostrovršnik J, et al. Incidence of IgA vasculitis in the adult Slovenian population. Br J Dermatol  2014; 171(3): 524-7.
 [http://dx.doi.org/10.1111/bjd.12946] [PMID: 24601900]

[8]
Hwang HH, Lim IS, Choi BS, Yi DY. Analysis of seasonal tendencies in pediatric Henoch–Schönlein purpura and comparison with outbreak of infectious diseases. Medicine (Baltimore)  2018; 97(36): e12217.
 [http://dx.doi.org/10.1097/MD.0000000000012217] [PMID: 30200139]

[9]
Kao GF, Evancho CD, Ioffe O, Lowitt MH, Dumler JS. Cutaneous histopathology of Rocky Mountain spotted fever. J Cutan Pathol  1997; 24(10): 604-10.
 [http://dx.doi.org/10.1111/j.1600-0560.1997.tb01091.x] [PMID: 9449487]

[10]
Bal AK, Kairys SW. Kawasaki disease following Rocky Mountain spotted fever: A case report. J Med Case Reports  2009; 3(1): 7320.
 [http://dx.doi.org/10.4076/1752-1947-3-7320] [PMID: 19830185]

[11]
Rasmussen C, Tisseyre M, Garon-Czmil J, et al. Drug-induced IgA vasculitis in children and adults: Revisiting drug causality using a dual pharmacovigilance-based approach. Autoimmun Rev  2021; 20(1): 102707.
 [http://dx.doi.org/10.1016/j.autrev.2020.102707] [PMID: 33197572]

[12]
Rustmann WC, Carpenter MT, Harmon C, Botti CF. Leukocytoclastic vasculitis associated with sotalol therapy. J Am Acad Dermatol  1998; 38(1): 111-2.
 [http://dx.doi.org/10.1016/S0190-9622(98)70550-X] [PMID: 9448217]

[13]
Hasbal NB, Baştürk T, Koç Y, Sahutoğlu T, Bayrakdar Çağlayan F, Ünsal A. Leukocytoclastic vasculitis associated with a new anticoagulant: Rivaroxaban. Turk J Haematol  2017; 34(1): 116-7.
 [http://dx.doi.org/10.4274/tjh.2016.0353] [PMID: 27796264]

[14]
Lee HL, Kim L, Kim CW, Kim JS, Nam HS, Ryu JS. Case of both rivaroxaban- and dabigatran-induced leukocytoclastic vasculitis, during management of pulmonary thromboembolism. Respir Med Case Rep  2019; 26: 219-22.
 [http://dx.doi.org/10.1016/j.rmcr.2019.01.017] [PMID: 30740299]

[15]
Pelleg T, Kadakia RS, Siddiqui F, Biscardi F, Ie S. Sotalol induced diffuse alveolar hemorrhage. In: C43 Drug Induced Lung Disease: Case Reports.  American Thoracic Society 2017; pp. A5569-9.

[16]
Rocky Mountain spotted fever data [Internet]. Illinois.gov.  Available from: https://dph.illinois.gov/topics-services/diseases-and-conditions/diseases-a-z-list/rocky-mountain-spotted-fever/data.html [cited April 3, 2022].

[17]
Biggs HM, Behravesh CB, Bradley KK, et al. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever and other spotted fever group rickettsioses, ehrlichioses, and anaplasmosis - United States: A practical guide for health care and public health professionals. MMWR Recomm Rep  2016; 65(2): 1-44.
 [http://dx.doi.org/10.15585/mmwr.rr6502a1] [PMID: 27172113]

[18]
Podjasek J, Wetter D, Pittelkow M, Wada D. Henoch-Schönlein purpura associated with solid-organ malignancies: Three case reports and a literature review. Acta Derm Venereol  2012; 92(4): 388-92.
 [http://dx.doi.org/10.2340/00015555-1288] [PMID: 22293661]

[19]
Hankard A, Michot JM, Terrier B, et al. New insights on IgA vasculitis with underlying solid tumor: A nationwide French study of 30 patients. Clin Rheumatol  2021; 40(5): 1933-40.
 [http://dx.doi.org/10.1007/s10067-020-05455-z] [PMID: 33099711]

Rights & Permissions Print Cite

Article Metrics

39

2

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/1573397118666220623105703	Print ISSN 1573-3971
Publisher Name Bentham Science Publisher	Online ISSN 1875-6360

Current Rheumatology Reviews

Case Report of Sotalol Induced IgA Vasculitis

Abstract

Graphical Abstract

Related Books